Correlation Between Hookipa Pharma and Mediwound

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Mediwound at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Mediwound into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Mediwound, you can compare the effects of market volatilities on Hookipa Pharma and Mediwound and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Mediwound. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Mediwound.

Diversification Opportunities for Hookipa Pharma and Mediwound

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Hookipa and Mediwound is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Mediwound in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mediwound and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Mediwound. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mediwound has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Mediwound go up and down completely randomly.

Pair Corralation between Hookipa Pharma and Mediwound

Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Mediwound. In addition to that, Hookipa Pharma is 1.62 times more volatile than Mediwound. It trades about -0.46 of its total potential returns per unit of risk. Mediwound is currently generating about -0.05 per unit of volatility. If you would invest  1,757  in Mediwound on August 28, 2024 and sell it today you would lose (67.00) from holding Mediwound or give up 3.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Hookipa Pharma  vs.  Mediwound

 Performance 
       Timeline  
Hookipa Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hookipa Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Mediwound 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mediwound has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Hookipa Pharma and Mediwound Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hookipa Pharma and Mediwound

The main advantage of trading using opposite Hookipa Pharma and Mediwound positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Mediwound can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mediwound will offset losses from the drop in Mediwound's long position.
The idea behind Hookipa Pharma and Mediwound pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
CEOs Directory
Screen CEOs from public companies around the world